ZM-412

N/A

Report date: 2024/06/28 16:56:08
NME

Base Information

Drug NameZM-412
Drug Alias NameZM-412
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKinesin-like protein KIF18A inhibitors
TargetsKinesin-like protein KIF18A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing Simcere Dongyuan Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Simcere Dongyuan Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A